1
|
Santos T, Ventura T, Lopes MDC. A review on radiochromic film dosimetry for dose verification in high energy photon beams. Radiat Phys Chem Oxf Engl 1993 2021. [DOI: 10.1016/j.radphyschem.2020.109217] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
2
|
Kazantsev P, Lechner W, Gershkevitsh E, Clark CH, Venencia D, Van Dyk J, Wesolowska P, Hernandez V, Jornet N, Tomsej M, Bokulic T, Izewska J. IAEA methodology for on-site end-to-end IMRT/VMAT audits: an international pilot study. Acta Oncol 2020; 59:141-148. [PMID: 31746249 DOI: 10.1080/0284186x.2019.1685128] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Background: The IAEA has developed and tested an on-site, end-to-end IMRT/VMAT dosimetry audit methodology for head and neck cases using an anthropomorphic phantom. The audit methodology is described, and the results of the international pilot testing are presented.Material and methods: The audit utilizes a specially designed, commercially available anthropomorphic phantom capable of accommodating a small volume ion chamber (IC) in four locations (three in planning target volumes (PTVs) and one in an organ at risk (OAR)) and a Gafchromic film in a coronal plane for the absorbed dose to water and two-dimensional dose distribution measurements, respectively. The audit consists of a pre-visit and on-site phases. The pre-visit phase is carried out remotely and includes a treatment planning task and a set of computational exercises. The on-site phase aims at comparing the treatment planning system (TPS) calculations with measurements in the anthropomorphic phantom following an end-to-end approach. Two main aspects were tested in the pilot study: feasibility of the planning constraints and the accuracy of IC and film results in comparison with TPS calculations. Treatment plan quality was scored from 0 to 100.Results: Forty-two treatment plans were submitted by 14 institutions from 10 countries, with 79% of them having a plan quality score over 90. Seventeen sets of IC measurement results were collected, and the average measured to calculated dose ratio was 0.988 ± 0.016 for PTVs and 1.020 ± 0.029 for OAR. For 13 film measurement results, the average gamma passing rate was 94.1% using criteria of 3%/3 mm, 20% threshold and global gamma.Conclusions: The audit methodology was proved to be feasible and ready to be adopted by national dosimetry audit networks for local implementation.
Collapse
Affiliation(s)
| | - Wolfgang Lechner
- Department of Radiation Oncology, Division of Medical Physics, Medical University of Vienna, Vienna, Austria
- Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Vienna, Austria
| | | | - Catharine H. Clark
- Department of Medical Physics, Royal Surrey County Hospital, Guildford, UK
- Metrology for Medical Physics (MEMPHYS), National Physical Laboratory, Teddington, UK
| | | | - Jacob Van Dyk
- Department of Oncology and Medical Biophysics, Western University, London, Canada
| | | | - Victor Hernandez
- Department of Medical Physics, Hospital Sant Joan de Reus, IISPV, Tarragona, Spain
| | - Nuria Jornet
- Servei de Radiofisica i Radioproteccio, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - Milan Tomsej
- CHU Charleroi, Hopital Andre Vesale, Montigny-le-Tilleul, Belgium
| | | | | |
Collapse
|